• JPMorgan initiated coverage of Relay Therapeutics with an 'Overweight' rating and a $28.00 price target.
  • H.C. Wainwright raised its price target to $28.00, and Guggenheim increased its target to $26.00.
  • The stock is trading at $20.50, reflecting a +4.44% increase today.